Accessibility Menu
MediPal logo

MediPal(OTC) MAHLY

Market Cap$3.75BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)+57%
5 Year+5%
1 Year+7%
1 Month-0%
$18.30
+0.23%
+0.04Today
MediPal last closing stock price
MetricPriceDate
Last closeUSD 18.302026-09-01
MediPal stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.23%USD 18.262026-08-25
1 month-0.02%USD 18.302026-07-29
3 month-3.7%USD 19.002026-06-03
Year to date+3.46%USD 17.682025-12-30
1 year+7.02%USD 17.102025-08-29
3 year+14.48%USD 15.982023-09-01
5 year+5.1%USD 17.412021-08-27
Since inception+56.79%USD 11.672008-12-22

MediPal Financials at a Glance

Market Cap

$3.75BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

¥3.93T

Net Income (TTM)

¥47.36B

EPS (TTM)

$1.47

P/E Ratio

12.42

Dividend

$0.42

Beta (Volatility)

-0.03 (Low)

Price

$18.30

Volume

4

Open

$18.30

Previous Close

$18.30

Daily Range

$18.30 - $18.30

52-Week Range

$15.37 - $20.35

Estimated Earnings Date

May 11, 2026

MAHLY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About MediPal

MediPal Holdings Corporation is a Tokyo-based wholesaler of prescription pharmaceuticals, established in 1898. The company also supplies a wide range of healthcare products and services, including medical equipment and clinical diagnostic reagents, catering to various sectors within the healthcare industry.

Products and Services
  • Wholesale distribution of prescription pharmaceuticals across Japan
  • Supply of medical equipment, clinical diagnostic reagents, and healthcare-related products
  • Specialized services including epidemiological studies and health insurance solutions
Growth Outlook
  • Revenue increased to JPY 1.002 trillion in Q1 2026, up from JPY 922 billion in Q4 2025
  • Net income rose to JPY 13.83 billion in Q1 2026, reflecting strong operational performance
  • Consistent demand for healthcare products supports long-term growth potential
Financial Highlights
  • Trailing twelve-month revenue of JPY 3.8 trillion, indicating robust market presence
  • Net profit margin of 1.21% for the trailing twelve months, showcasing operational efficiency
  • Dividend yield of 2.34%, providing attractive returns to shareholders
MediPal Holdings Corporation operates in the medical distribution sector, focusing on the wholesale of pharmaceuticals and healthcare products. The company has demonstrated strong financial performance, with a significant increase in revenue and net income in the most recent quarter. The growth in revenue from JPY 922 billion in Q4 2025 to JPY 1.002 trillion in Q1 2026 highlights the company's ability to capitalize on the increasing demand for healthcare products. Additionally, the net profit margin of 1.21% reflects effective cost management and operational efficiency. The company's diverse product offerings and specialized services position it well within the healthcare industry, catering to hospitals, clinics, and various retail outlets. With a solid dividend yield of 2.34%, MediPal presents an appealing option for investors seeking both growth and income. The ongoing demand for healthcare solutions further supports the company's long-term growth outlook, making it a noteworthy consideration for potential investors.
AI Generated • Aug 17, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

13,024

CEO

Shuichi Watanabe

Website

www.medipal.co.jp

Headquarters

Tokyo, TY 104-8461, JP

MAHLY Financials

Key Financial Metrics (TTM)

Gross Margin

6.43%

Operating Margin

1.36%

Net Income Margin

1.21%

Return on Equity

7.26%

Return on Capital

8.61%

Return on Assets

2.40%

Earnings Yield

8.05%

Dividend Yield

2.28%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.75BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

204.70M

Volume

4

Avg. Volume

136.078

Financials (TTM)

Gross Profit

¥252.46B

Operating Income

¥53.40B

EBITDA

¥101.32B

Operating Cash Flow

¥0.00

Capital Expenditure

¥0.00

Free Cash Flow

¥0.00

Cash & ST Invst.

¥288.01B

Total Debt

¥42.94B

MediPal Performance Analysis

MediPal annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31JPY 24,803,906,184-15.3%
20242024-03-31JPY 24,642,667,726-0.7%
20252025-03-31JPY 24,082,119,822-2.3%
20262026-03-31JPY 25,332,146,6855.2%
MediPal sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-302.5%
Q32025-12-316.5%
Q42026-03-31-10.7%
Q12026-06-308.7%
MediPal annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31JPY 1.3213.1%
20242024-03-31JPY 1.362.5%
20252025-03-31JPY 1.27-6.5%
20262026-03-31JPY 1.378.2%
MediPal sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-09-3034.3%
Q32025-12-3122.6%
Q42026-03-31-66.4%
Q12026-06-30165.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

¥1.00T

+6.1%

Gross Profit

¥63.04B

-2.5%

Gross Margin

6.29%

N/A

Market Cap

$3.75BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$287.58K

N/A

Employees

13,024

N/A

Net Income

¥13.83B

+44.2%

EBITDA

¥18.33B

+5.3%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

¥288.01B

+17.1%

Total Debt

¥42.94B

+15868.1%

Accounts Receivable

¥829.31B

+3.0%

Inventory

¥193.57B

+6.7%

Long Term Debt

¥42.94B

N/A

Short Term Debt

¥0.00

N/A

Return on Assets

2.40%

N/A

Return on Invested Capital

6.19%

N/A

Free Cash Flow

¥0.00

N/A

Operating Cash Flow

¥0.00

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ANSLYAnsell Limited
$107.84+0.00%
SNPHYSanten Pharmaceutical Co., Ltd.
$11.95+6.41%
ANSLFAnsell Limited
$21.64+0.00%
SHWGYShandong Weigao Group Medical Polymer Company Limited
$1.50+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$10.38+0.11%
NVDANvidia
$228.45+0.02%
SPCXSpace Exploration Technologies
$149.74+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$11.01+0.06%

Questions About MAHLY

What is the current price of MediPal?

MediPal is trading at $18.30 per share.

What is the 52-week range for MediPal?

Over the past 52 weeks, MediPal has traded between $15.37 and $20.35.

How much debt does MediPal have?

As of the most recent reporting period, MediPal reported total debt of ¥265.99M.

How much cash does MediPal have on hand?

MediPal reported ¥1.78B in cash and cash equivalents in its most recent financial results.

What is MediPal’s dividend yield?

MediPal currently has a dividend yield of 2.28%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services